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ABSTRACT 
Despite the significant improvements made to address addiction and drug 
diversion by healthcare personnel, the issue continues to be problematic for most 
healthcare facilities. Current literature suggests that healthcare institutions incorporate 
early drug diversion and addiction education, implementation of effective policies and 
procedures, and continuous drug screening will strongly aid in decreasing the prevalence 
of drug diversion by healthcare providers.  
 Among all the different types of healthcare providers, anesthesia providers 
continue to be at a disproportionately higher risk for addiction and drug diversion when 
compared to other providers (AANA, 2016).  The stress of a demanding profession, 
personality, and easy access to addictive medications all play a part in this statistic, thus, 
are responsible for the increased risk of addiction and drug diverting by anesthesia 
providers (Wright et al., 2012).  The disease of addiction and the act of drug diversion is 
a multifaceted problem that affects the healthcare provider, coworkers, hospitals, patients, 
and families.  Therefore, it is imperative that healthcare institutions have policies and 
procedures in place that comply with current best practice guidelines regarding employee 
drug diversion.  The purpose of this DNP project was to perform a policy analysis on the 
institution of interest drug diversion reporting and response policy.  A SWOT analysis 
was performed and after a thorough review of the evidence, a set of best practice 
guidelines regarding a drug diversion policy were used to compare the participating 
facility’s current policy for reporting drug diversion in an employee.  An executive 
summary of policy analysis findings and suggested revisions to the institution’s current 
policy was presented to the key participants.   
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CHAPTER I - INTRODUCTION 
Substance abuse is a topic of concern in the practice of Certified Registered Nurse 
Anesthetist (CRNA).  According to the American Association of Nurse Anesthetist 
(AANA, 2015), 1 out of every 10 CRNAs is misusing drugs within the workplace.  
Substance abuse, thus addiction, is an illness that is difficult to understand and is a 
disease that spans our entire economic and social spectrum (AANA, 2015).  A term 
associated with substance abuse is drug diversion.  For the purpose of this project, “drug 
diversion” is used in reference to the act of a healthcare provider redirecting drugs for 
personal use both on and off duty (AANA 2016).  Drug diversion is a considerable 
problem in healthcare facilities around the world (Bell, McDonough, Ellison, & Fitzhugh, 
1999).  Substance abuse and drug diversion in the workplace is an issue that must never 
be ignored because of its importance to both patient and provider safety.  An impaired 
provider, specifically the CRNA profession, who is diverting drugs cannot deliver safe 
anesthesia or respond to an emergency appropriately, thus placing the patient in harm’s 
way (AANA, 2015).  Review of evidence reveals that within healthcare institutions, early 
education, vigorous programs, effective processes, and the continuous use of screening 
can aid in decreasing the prevalence of substance abuse and drug diversion among 
healthcare professionals (AANA, 2015).   
Background and Significance 
Anesthesia providers are at a disproportionately higher risk for substance abuse 
when compared to other healthcare professionals (Wright et al., 2012).  A variety of 
reasons, including the stress of a demanding profession, personality traits among CRNAs 
and access to highly addictive medications, are responsible for the increased statistics 
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among anesthesia providers Wright et al., 2012).  It is estimated that 10-20% of nurse 
anesthetists will experience some form of drug misuse during their career (Bell et al., 
1999).  Chemical dependency in an anesthesia provider occurs most frequently in the first 
five years of practice, according to the fact sheet provided by AANA (2015).  If that 
statistic was not alarming enough, Tetzlaff (2011), stated the leading cause of death 
among young anesthesia providers is substance abuse.  Despite the alarming statistics, 
many would argue the statistics are “off” or “not accurate” due to the difficulty it is to 
obtain the accurate frequency of substance abuse and drug diversion, not only among 
anesthesia providers but in healthcare providers as a whole (Wright et al., 2012).  Legal 
issues, risk of losing licensure, policy, and processes in place by institutions and patient 
safety, all play a role in obtaining accurate data pertaining to confirmed substance abuse 
and/or drug diversion by healthcare personnel, thus, making this problem more likely 
larger than we know (Wright et al., 2012).   
The AANA acknowledges the risk anesthesia providers face and in 1984, the 
AANA adopted the AANA Position Statement 1.7 Chemical Dependency.  The position 
statement has since been revised to the AANA Position Statement 1.7 Substance Misuse 
and Chemical Dependency.  Over the years, the AANA has continued to recognize the 
disease of addiction and what it means for the anesthesia community.  AANA has 
developed multiple wellness programs and Peer Assistance Advisors (PAA) groups in 
every state that provide 24-hour phone hotline service for those in need.  The American 
Nurses Association (Strobbe & Crowley, 2017) has also taken a stance against nursing 
impairment and defines it as a “nurse who is unable to meet the requirements of the 
Professional code of ethics established by the ANA as a result of cognitive, interpersonal 
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or psychomotor dysfunction from excessive use of alcohol or drugs” (p. 105).  Seventy 
percent of all disciplinary cases addressed by the state board of nursing are related to the 
chemically impaired nurse (National Council of State Boards of Nursing [NCSBN]), 
2011).   
Substance abuse and the disease of addiction not only affects the healthcare 
provider but, also, the patients who have entrusted the provider to keep them safe 
(Kunyk, 2015).  Abuse among healthcare providers is often not recognized until death or 
a near-death overdose has occurred (ANA, 2015).  Because of this fact, it is crucial that 
every institution have policy and prevention programs in place to prevent, detect, report 
and respond to drug diversion (AANA, 2016).  The American Nurse Association (ANA, 
2015) educates that in addition to nurses and advanced practice nurses, ancillary staff 
may also have access to medications, thus, providing an opportunity for the diversion of 
drugs.  Warner et al. (2015) reported on a surgical technician who diverted opioids by 
replacing fentanyl syringes with syringes filled with saline that were now contaminated.  
In this report by Warner et al. (2015), an unknown number of patients were exposed to 
hepatitis C, but 18 patients were confirmed to be infected with the virus.   
Best practice guidelines regarding drug diversion policy emphasize the 
importance of facilities to have clear and specific policies in place for drug diversion in 
the workplace.  Processes and procedures that include early education, drug diversion 
programs, clear guidelines for reporting diversion, effective management of confirmed 
diversion and the transition to treatment are all key steps in the prevention of adverse 
outcomes related to drug diversion (AANA, 2016).  Policies that advocate for fair and 
uniform management help create the safe environment for “prompt reporting, appropriate 
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treatment, and the potential for reentry of the professional into clinical practice” (Lien, 
2012, p. 607).  Therefore, it is important to determine the most effective ways to decrease 
the risk of substance abuse and drug diversion among all healthcare providers, including 
students who are utilizing hospitals for clinical gain.  Chronic stress places the anesthesia 
students at an increased risk for illness, injury to self and substance abuse (Bozimowski, 
Groh, Rouen, & Dosch, 2014).  The AANA (2015) believes the lack of SRNA education 
related to effective coping skills and recognizing the signs and symptoms of risky 
behaviors can contribute to this problem.  There are multiple risk factors that contribute 
to the risk of substance abuse as a provider, but stress is a precursor in anesthesia 
programs and in the early years of practicing (Bozimowski et al., 2014).  Healthcare 
facilities, administration, and nursing programs have a responsibility to ensure that the 
processes, policy, and security systems are in place to prevent drug diversion and to 
protect patients if impairment is suspected (ANA, 2015).  
Problem Statement 
Anesthesia providers are often in contact with controlled substances.  The 
progression of substance abuse is rapid and coupled with a very high morbidity and 
mortality rate (Tetzlaff, 2011).  Substance abuse and drug diversion is a multifaceted 
problem that affects providers, co-workers, employers, patients and families (Berge, 
Dillon, Sikkink, Taylor, & Lanier, 2012).  The AANA (2016) estimates diversion and 
addiction of anesthesia providers at greater than 15%.  The ANA (2015) estimates that 6-
8% of nurses use alcohol or drugs to the extent that it impairs professional performance. 
The impaired provider poses a significant threat not only to patient safety but also 
become a liability to the health care institutions and departments where the diversion 
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occurred. (ANA, 2015).  The clinical question for this DNP project asks, Does the drug 
diversion policy at a Level II hospital in southeast Mississippi follow best practice 
guidelines regarding healthcare employees? 
Purpose of Project 
The purpose of this DNP project was to perform a policy analysis on the drug 
diversion reporting and response policy at a local hospital.  Clear policies and procedures 
should be set in place for dealing with such investigations and managing the many 
possible outcomes of a confirmed diversion.  The policy was compared to current best 
practice guidelines for drug diversion policies and prevention within healthcare facilities. 
The student developed a new language for the policy related to suspected or confirmed 
drug diversion in student registered nurse anesthetists.  Educational modules were also 
developed for the local facility and anesthesia program to utilize as part of their efforts to 
decrease the incidence of drug diversion amongst present and future anesthesia providers.  
Needs Assessment 
A needs assessment was performed and a gap in the current drug diversion policy, 
when compared to the best practice guidelines at a local hospital, was found.  The drug 
diversion policy at the local facility in south Mississippi lacked the appropriate language 
needed in their policy related to the impaired anesthesia student.  In the policy, there is a 
gap in terms of what supervisors and managers do for their employees which are not 
appropriate for the student and academic partners dealing with a drug diversion incident.  
The facility of interest was asked to provide a policy, based on best practice guidelines, 
specifically related to drug diversion in student registered nurse anesthetists.   Also, a 
complete analysis was performed on the drug diversion reporting and response policy and 
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compared to best practice guidelines.  Thus, the policy problem question addressed the 
enhancements needed in the policy so that it meets all best practice guidelines suggested 
for an effective drug diversion policy.  Evaluation of the gaps between the current 
evidence and the current policy at the local hospital was also performed.  Collaboration 
between all parties involved, but specifically, the hospital and the university, are 
necessary for effective action to be taken when drug diversion is confirmed in a student.   
Theoretical Framework 
 The model that aided in the policy analysis is Bardach's model.  Bardach's model 
recommends summarizing the policy issues, evaluating the supporting and opposing 
arguments, analysis of stakeholders and anticipated impact on sentinel outcomes.  There 
are eight steps included in Bardach's model.  The eight steps include: define the problem, 
assemble the evidence, construct the evidence, select the criteria, project the outcomes 
confront the tradeoffs, decide and finally, and tell your story.  Steps one through four 
focus on framing the analysis, while steps five through eight emphasize actually doing 
the analysis and disseminating findings.  The impact on outcomes, according to Bardach's 
model, includes evaluating population health benefits, costs, and equity and 
administrative feasibility.  The “tell your story” stage of Bardach's model, culminates 
with the presentation of findings to key internal stakeholders at the local hospital that 
includes the policy analysis and evaluation with recommendations for policy changes 
within the hospital, an algorithmic plan for reporting drug diversion in SRNAs and 
educational modules.  
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DNP Essentials 
There are eight essential elements of the Doctor of Nursing Practice (DNP) degree 
(AACN, 2006).  Each of those eight essentials were met in the development of this 
project and are listed as follows: 
Essential I: Scientific Underpinnings for Practice 
Essential one was met by completing an evidence review of the topic, exploring 
the scientific knowledge previously discovered.  The evidence discovered will aid in 
developing best practice guidelines for a drug diversion policy.  
Essential II: Organizational and Systems Leadership for Quality Improvement and 
Systems Thinking 
Essential II focuses on quality improvement and systems thinking, which was met 
by performing a policy analysis, along with the development of educational modules.   
Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based Practice 
Essential III was met through an integrated review of evidence and analysis of the 
best practice guidelines for drug diversion policy in healthcare institutions.   
Essential IV: Information Systems/Technology and Patient Care Technology for the 
Improvement and Transformation of Health Care 
Information systems and technology was utilized by formatting a policy algorithm 
used as part of improving the drug diversion reporting and response policy at the facility 
of interest.  
Essential V: Health Care Policy for Advocacy in Health Care 
Essential V was met by analyzing the current drug diversion policy at the hospital 
of interest as means to update policy to meet demands by best practice guidelines.   
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Essential VI: Interprofessional Collaboration for Improving Patient and Population 
Health Outcomes 
Continuous collaboration with hospital research committee, anesthesia and 
pharmacy departments necessary for the success of this DNP project targeted outcome, 
Essential VI was met.  
Essential VII: Clinical Prevention and Population Health for Improving the Nation’s 
Health 
Essential VII was met through a policy analysis performed and the development 
of education modules on addiction and drug diversion.  The modules will be used as a 
way to bring drug diversion awareness to all hospital employees and students.   
Essential VII: Advanced Nursing Practice 
The analysis of evidence, synthesis of data, presentation of findings and the 
assessment of the impact of the information presented to key stakeholders are all 
expected of the advanced practice nurse, therefore this essential was met. 
Review of the Evidence 
An evidence search was performed to explore the best practice guidelines for drug 
diversion policies and procedures in healthcare facilities.  A secondary search was done 
to explore the disease of addiction, signs, and symptoms of drug diversion, available 
resources, and best practice prevention guidelines.  Several databases including CINAHL 
with Full Text, Medline, PubMed, Cochrane, and Google Scholar were searched for 
relevant articles.  The following search terms were utilized: addiction, drug diversion, 
anesthesia, substance abuse, impaired provider.  An initial search with limitations to full 
text only and publication dates between 2000 and 2016 returned 114 articles after 
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duplications were removed.  Upon further review of all databases accessed, 10 articles 
were selected because they were strongly applicable to this project.  An evidence matrix 
is included with information from each of the included articles (See Appendix B).  
Addiction is a Disease 
Our nation is in the midst of an unprecedented opioid epidemic (U. S. Department 
of Health & Human Services, 2016).  On an average day in the United States, 3,900 
people initiate a nonmedical use of opioids (MSDH.ms.gov).  In the state of Mississippi 
alone, 3.3 million opioid prescriptions were dispensed in 2016 (MSDH.ms.gov).  On 
average, for every Mississippi resident, there were 2.4 allocated for controlled substances 
and 1.1 prescriptions for opioid analgesics during 2016 (MSDH.ms.gov).   
Substance-use disorder (SUD) is the diagnostic term in the fifth edition of the 
Diagnostic and Statistical Manual of Mental Disorders referring to the recurrent use of 
alcohol or other drugs that causes clinically and functionally significant impairment 
(Substance Abuse and Mental Health Services Administration (SAMHSA, 2017).  The 
impairment is so significant, individuals are unable to meet the responsibilities at work, 
school or home that they once were able to do. Substance use disorders are 
neurobiological disorders, they are not a choice to abuse or become dependent on a 
substance (SAMHSA, 2017).  Once someone is addicted, there is a complete loss of self-
control and compulsive drug taking behaviors, despite the intense desire to stop taking 
the drugs (SAMHSA, 2017).  Scientific evidence shows that disruptions in three areas of 
the brain are particularly important in the onset, development, and maintenance of 
substance use disorders: the basal ganglia, the extended amygdala, and the prefrontal 
cortex (SAMHSA, 2017).  These disruptions enable substance-associated cues to trigger 
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substance seeking, reduce sensitivity of brain systems involved in the experience of 
pleasure or reward, and heighten activation of brain stress systems and reduce 
functioning of brain executive control systems, which are involved in the ability to make 
decisions and regulate one’s actions, emotions, and impulses (Health Care Systems and 
Substance Use Disorders, 2018).  
Impaired Healthcare Professional 
Multiple studies confirm the presence of substance abuse among anesthesia 
providers.  The term anesthesia provider includes: certified registered nurse anesthetist, 
student registered nurse anesthetist, anesthesiologists, and anesthesiology residents.  
Saunders (2006) revealed a lack of awareness of the actual systematic plan in place to 
handle the problems of alcohol and drugs within hospitals.  In more cases than not, 
providers are not tested for drugs until they are reported by a co-worker for displaying 
obvious signs and symptoms of impairment (Saunders, 2006).  Shared risk factors for 
anesthesia providers, in general, include easy access to narcotics, the stress of profession, 
schedule irregularities, sleep deprivation, and requirement of absolute vigilance 
overextended surgical procedures (Luck & Hedrick, 2004).  A correlational study by Bell 
et al. (1999) found that male CRNAs with 6-10 years of experience were at the highest 
risk for substance abuse.  High academic performance is also a risk factor as evidenced 
by the top 10% of SRNAs showed higher addiction rate (Tetzlaff, 2011).  According to 
Tetzlaff (2011), the anesthesia work environment (e.g., the operating room) is ideal for 
drug diversion and dependency. Bell et al. (1999) and Luck and Hedrick (2004) found 
that versed and nitrous oxide are the two most commonly abused drugs among anesthesia 
providers.  On the contrary, Berge, Dillon, Sikkink, Taylor, and Lanier (2012) reported 
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that opioids are the most diverted drugs.  Specifically, to opioids, Tetzlaff (2011) stated 
fentanyl was the most abused opioid among anesthesia providers. According to AANA 
(2016), the prevalence of anesthesia providers diverting drugs for self-administration is 
9.8%.  
The AANA (2015) highlights that knowledge of signs and behaviors of an 
impaired provider is vital; however, the AANA also recognizes that identifying 
impairment in a colleague is difficult.  Difficulty in identifying impairment may be due to 
the fact that these changes in behavior may not be abrupt.  According to the AANA, as 
cited in Luck and Hendrick (2004), these behavior changes may occur little by little, over 
the course of months or years, making them complicated to identify.  To make the 
situation more difficult, impaired providers conceal their addiction in many different 
ways.  Addicts may alter their charting to show certain drugs were given, when in fact, 
another drug was given, or sometimes, to the detriment of the patient, none were given at 
all; some addicts may replace their drug of choice with another liquid, as if the drug had 
never been tampered with at all (Bryson & Silverstein, 2008).  Anita Bertrand, a Certified 
Registered Nurse Anesthetist practicing in Houston, stated, “I was absolutely impaired, 
using narcotics while working...And no one ever noticed;” she even placed an 
intravenous port in her ankle for easier access to administer her drug of choice (Eisler, 
2014., p. 1).  Bertrand stated, “There are so many practitioners working impaired and we 
have no idea...we’re doing a terrible job addressing this problem” (Eisler, 2014., p. 2).   
Anesthesia providers have an in-depth knowledge of medications that give them 
an advantage when choosing their drug of choice for abuse (Wright et al., 2012).  Most of 
the drugs chosen are difficult to detect due to short half-lives, making blood and urine 
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tests unreliable.  There are multiple reasons why anesthesia providers divert drugs.  
According to Tetzlaff (2011), the authors agree that previous drug experimentation is 
associated with future substance abuse and has been confirmed by interviews of 
recovering anesthesia providers.   A majority of addicted anesthesia providers have a 
novelty-seeking behavior and a history of personality disorders that lead to self-
medication and drug diversion (Tetzlaff, 2011).   
As mentioned above, ineffective coping related to the stress of anesthesia school 
can lead the student down a path of poor decision making and self-treatment.  A study by 
Perez and Carrol-Perez (1999) examined anesthesia students’ perception of stress.  Of the 
1,504 student responses, 73% reported their stress was categorized as a major life crisis 
(Perez & Carrol-Perez, 1999).  The statistics of substance abuse and drug diversion 
among anesthesia professionals needs to be disclosed to the students in anesthesia 
programs (Wright et al., 2012).  Anesthesia students should be aware of the resources 
available through the school or through professional organizations, so they may utilize 
them if needed (Bozimowski et al., 2014).  Students should be knowledgeable in drug 
diverting signs and behaviors, so easy detection can be made (Bozimowski et al., 2014).  
The guidelines SRNAs follow when drug diversion is suspected should be easily 
accessible in the event the steps need to be followed (Bozimowski et al., 2014).     
Prevention in the Workplace 
Another common theme in the review of literature is the need for supplemental 
education and policy development regarding substance abuse and drug diversion in 
anesthesia providers.  The AANA (2016) recommends the use of a thorough drug 
diversion program and an unbiased substance abuse policy by healthcare institutions.   
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Within the drug diversion program, education to identify signs and behaviors of drug 
diversion and steps to take if one suspects abuse should be of paramount importance.  
However, the policy guidelines should be made clear to all employed staff and students 
utilizing the facility for training purposes (AANA, 2016).  There have been several 
studies that have attempted to identify interventions to prevent or deter substance abuse 
in anesthesia providers.  Berge et al. (2012) examined drug diversion in multiple facilities 
and the study included patterns, detection, and prevention of drug diversion.  
Interventions included random drug sample processing of returned controlled substances, 
automated drug distribution and return system and a more aggressive position of 
prevention coordinators and committees.  The authors did report an overall decline in 
drug diversion, however, the data was limited, and no clear findings were indicated.  
According to AANA (2016), a policy that builds awareness of individual risk factors 
identifies signs and symptoms of substance abuse and utilizes drug diversion prevention 
strategies, may discourage diversion and substance use while keeping patients and 
providers safe.  
By its nature, drug diversion is a clandestine activity, and methods in place in 
many institutions leave cases undiscovered and unreported (Bell et al., 1999).  The 
review of the evidence suggests there needs to be ongoing efforts to prevent the diversion 
of controlled substances from the workplace and to rapidly identify and respond when 
such diversion is detected (Berge et al., 2012, p. 65).  Healthcare facilities must have 
systems in place to promptly identify drug diversion and intervene when it is occurring 
(Berge et al., 2012). All healthcare workers must be vigilant for signs of diversion.  It is 
an accreditation requirement by the Council on Accreditation of Nurse Anesthesia 
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Educational Programs (COA) that all graduate and doctoral level nurse anesthesia 
programs include the subject of substance abuse in their curriculum.  The COA does not 
lay out specific guidelines or tools for schools to follow to make sure consistent 
education about substance abuse is being followed.  However, the current literature does 
put emphasis on the continuation of education on substance abuse after entry to 
professional anesthesia practice.  The AANA peer mentoring committee has provided 
support for anesthesia providers struggling with addiction.  Modules and current statistics 
are available on the AANA website to all anesthesia providers, programs and 
departments to utilize within their specialties as a means to provide education, show 
support and prevent issues related to substance abuse. The resources provided on the 
AANA website addressing substance abuse and drug diversion are made available, so 
policy can be developed or improved.   
Best Practice Guidelines 
The AANA (2017) recommends facilities address the important element of patient 
and provider safety through a comprehensive program and non-discriminatory policy 
addressing substance use disorder.  Substance use disorder should not be ignored. It can 
result in harm to the impaired individual, their colleagues or patients.  Regardless of the 
substance abused, impairment on the job can adversely impact patient and provider safety 
(Berge et al., 2012).   Facility policy and education that address symptom awareness, 
prevention, reporting, safe intervention, and reentry to the workplace, may minimize the 
risk of substance diversion and minimize adverse outcomes (Berge et al., 2012).  Policies 
that advocate for fair and uniform management of providers with suspected or diagnosed 
substance use disorder supports a safe environment for prompt reporting, appropriate 
 23 
treatment, and the possible reentry of the anesthesia professional into clinical practice 
(Berge et al., 2012).  According to the AANA, a policy that includes specific elements 
are complying with best practice guidelines.  These guidelines will aid in discouraging 
drug diversion and substance abuse in the workplace, while also promoting the well-
being of employees and patients.  The elements are as listed below:  
•   Promotes healthy behaviors to support professional responsibility to be fit for 
duty. 
•    Builds awareness of individual risk factors. 
•    Identifies behaviors and symptoms of substance use disorder and drug 
diversion. 
•    Acknowledges the harmful consequences of substance use disorder, drug 
diversion, and impairment in the workplace. 
•    Utilizes drug diversion prevention strategies. 
•    Optimizes drug testing modalities (e.g., pre-employment, random, for-cause) 
to include testing for anesthesia drugs. 
•   Outlines safe reporting processes of impaired individuals through the 
appropriate chain of command. 
•    Facilitates a safe intervention for appropriate treatment evaluation. 
•    Addresses specific treatment considerations for anesthesia professionals. 
•    Clarifies reporting obligations to authorities and/or licensing boards. 
•    Maintains a safe, stigma-free workplace environment (AANA, 2016). 
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Summary 
  Our nation is currently facing an opioid epidemic.  It is the duty, not only to our 
profession but to our patients to protect them from harm and provide the best quality care.  
Impaired healthcare personnel places themselves, the patient, and the profession at risk.  
Best practice guidelines suggest hospitals need to have clear policies set in place that 
provide all healthcare employees with the steps to be taken when reporting drug 
diversion.  This DNP project was able to perform a policy analysis of a current drug 
diversion policy at a hospital in southeast Mississippi.  The policy analysis followed 
Bardach’s model to policy analysis.  After a thorough review of the literature, best 
practice guidelines aided the student in analyzing the drug diversion policy.  All eight 
essential elements of the DNP degree were met in the development of this project.  
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CHAPTER II - METHODOLOGY 
Target Outcome 
The outcome of this doctoral project was to perform a policy analysis of the drug 
diversion policy at a healthcare facility located in southeast Mississippi.   An executive 
summary of suggested revisions to the current drug diversion policy was presented to key 
stakeholders who could incorporate the suggested findings into the policy in the future.  
Evidence gathered was not limited to anesthesia providers and SRNAs.  Review of 
evidence related to substance abuse in all healthcare professionals was also examined. 
After a thorough review of the evidence, a set of best practice guidelines for the 
facility’s’ drug diversion policy was established.  As part of ongoing education, modules 
were developed on drug diversion, signs and symptoms and the available resources if one 
suspects abuse.  It is a long-term goal of this project that the modules be required of not 
only current CRNAs, but also the anesthesia students who utilize the hospital in southeast 
Mississippi for clinical experience. 
Sample 
During the review of best practices, there were multiple populations studied.  The 
sample of this doctoral project was CRNAs and SRNAs who were either employed or 
working in a hospital in southeast Mississippi.  Other populations studied included 
registered nurses, pharmacists, and medical residents.    
Design 
A policy analysis was performed on a drug diversion reporting and response 
policy to detect the need for improvement of the process the facility utilizes.  It was the 
goal of this project to inform the local hospital of best practice guidelines and gaps in 
 26 
current policy related to drug diversion.  The outcomes management director at the 
healthcare facility of interest was notified of the project and sent the current policy to the 
DNP student.  A SWOT analysis (Appendix D) was performed to weigh the benefits and 
liabilities associated with the drug diversion policy.  The SWOT analysis identified the 
hospital's drug diversion policy’s strengths, weaknesses, opportunities, and threats to 
revising or replacing the current policy.  Evaluation of the gaps between the current 
suggested best practice guidelines and the current policy at the local hospital was also 
examined.  Many types of data resources were explored including, suggested guidelines 
for effective substance abuse policy, professional organizations, peer assistance resources 
and other facilities with effective drug diversion and substance abuse policies in place. 
The data resources also included state legislature, laws, and regulations on reporting 
substance abuse among the anesthesia provider.  The analysis of qualitative material was 
an active and interactive process initiated with an exploration for wider classifications or 
themes within the evidence.  This qualitative approach was employed to thoughtfully 
evaluate the drug diversion policy and compile suggested changes to be made to the 
policy for the hospital of interest. 
An executive summary of the findings, based on best practice guidelines and 
input from the multidisciplinary team involved, was developed.  After findings were 
disseminated to key stakeholders, the student presented the key objectives of the project 
to the anesthesia department along with an educational session on substance abuse and 
drug diversion behaviors.  The educational modules were developed with the goal of 
introducing the disease of addiction and the impact it has on the anesthesia profession.  
The modules aim to provide an effective and common grounding in drug diversion 
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behaviors, how to report suspected drug diversion and the resources available to 
providers in need.  The design of the modules used an outcome-based approach.  This 
approach is defined as what can the “students,” and in this case anesthesia personnel and 
anesthesia students, “do at the end of the modules.”  The DNP student developed a draft 
of the modules using PowerPoint Presentations.  The modules were also shown to key 
administrative and anesthesia-related participants.  As part of ongoing education, it is a 
long-term goal of this project that the modules be a requirement for anesthesia students 
entering clinical for the first time.  The presentation to administration and the anesthesia 
department included an opportunity for feedback and comments  
Barriers and Limitations 
While planning this doctoral project, it was important to identify positive and 
negative factors in implementing the overall project.  Utilizing the SWOT analysis in the 
early stages of planning, the student was able to identify the potential barriers and 
facilitators to the clinical process change.  The analysis revealed more strengths and 
opportunities than threats or weaknesses to implementation.  One strength includes the 
shared interest between the DNP student, hospital administration, and anesthesia 
department to improve processes and drug diversion policy guidelines.  However, 
barriers such as coworkers actually following policy and proper reporting process when 
an anesthesia provider is suspected of drug diversion will need to be addressed.  
According to Berge et al. (2012), most providers are not exactly sure how to address an 
impaired provider or student and do not want to be part of the reason he/she loses their 
job or license.  Even though the best practice suggests the use of standardized policies 
and procedures when dealing with these types of investigations, compliance from the 
 28 
employees within a department is key to carrying out these best practice guidelines 
(Berge et al., 2012). 
Ethical Considerations 
The University of Southern Mississippi Institutional Review Board (IRB) granted 
approval before the start of this project.  IRB approval from the institution of interest was 
not required due to the fact no human subjects are being studied.  Participants, such as the 
institution administration and research committee, were involved solely on a voluntary 
basis.  The DNP project was carried out following sound ethical principles.  After the 
policy analysis findings were disseminated to the participants, time for feedback was 
encouraged as part of the evaluation of this DNP project.  Feedback received from 
participants was documented by the student.  Participants were reassured all feedback and 
suggestions for the future of the policy is kept confidential. 
Summary 
The outcome of this DNP project was to perform a policy analysis of a facility’s 
drug diversion reporting and response policy.  Suggested policy revisions were presented 
to the key stakeholders and time was allotted for comments and feedback.  A long-term 
goal of this project included the use of the educational modules by the facility in the 
future.  This goal was met, and the facility of interest will be utilizing the modules in 
their institution as they seem fit.  The project faced limitations and anticipated potential 
barriers without any lengthy setback.  Sound ethical principles were carried out and 
followed throughout the entire process of this DNP project.  
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CHAPTER III – RESULTS 
Discussion of Results 
Seven of the 12 key stakeholders were present for the dissemination of the project 
findings.  Suggested areas to the current policy in need of change included financial 
responsibilities, reporting to legal agencies and language specific to students using the 
facility for clinical experience.  After suggested changes to existing policy were 
discussed with the key stakeholders at the institution of interest, time was allotted for 
stakeholders to give their feedback, comments or concerns.  Overall, the seven key 
stakeholders were very receptive to the suggested policy changes presented.  There was a 
unanimous agreement regarding the policy needing specific language related to steps 
taken when a SRNA is suspected and/or confirmed of drug diversion.  It was discussed 
that the facility would like to keep the language “simple”, if you will, in the sense it 
should not be specific to each school program.  The stakeholders had concerns when 
addressing each school, each department and each type of program that uses their 
facilities for clinical.  It was decided that there definitely needs to be new language added 
to the existing policy regarding clinical students (SRNAs, residents, physical therapy 
students), but the language needs to be written cohesively with the universities already 
existing drug diversion policies.  
The educational modules were presented to stakeholders via PowerPoint 
presentation and a copy were given to each one as well.  Feedback from stakeholders 
regarding the educational modules were positive.  All participants voiced the need to 
utilized modules throughout all departments at the facility.  Permission was asked to 
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utilize modules and statistics within.  The student agreed to allow the facility of interest 
to use the educational modules as they see fit for the future.   
Summary 
Seven of the 12 key stakeholders were present for the dissemination of policy 
analysis findings.  All stakeholders agreed that the current policy needs some revisions.  
The facility of interest requested permission to use the projects research and education 
modules as they see fit for their employees.  Permission was granted by the student.   
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CHAPTER IV – CONCLUSION 
Implications for Future Practice  
Policy analysis is an area of inexperience to most and the lack of research proves 
this.  The policy is the foundation of evidence-based practice.  The policy is very 
deliberate and guides decisions to achieve rational outcomes.  Through policy, hospitals 
around the world are able to provide patients with the best care possible.  Better patient 
outcomes drive policy decisions.  As stated throughout this paper, drug diversion 
reporting and response is an area of unfamiliarity.  Future research needs to be aimed at 
creating guidelines on how institutions should perform a policy analysis and how to 
implement the findings from the analysis into practice.  Research in the future should 
explore the effectiveness of continual drug diversion and wellness education programs 
already implemented at healthcare facilities.  
Interpretation of Results 
The purpose of this DNP project was to perform a policy analysis on a drug 
diversion reporting and response policy.  The review of literature and the best practice 
guidelines aided in the analysis of the facilities drug diversion policy.  Although, only 7 
of the 12 key stakeholders were present at the dissemination of the policy analysis, the 
overall impact the projects findings had were positive.  Evaluation of the project was 
based off the feedback given by the key stakeholders.  All parties involved agreed 
changes needed to be made to existing policy in order to meet the best practice guidelines 
for an effective drug diversion policy.  Permission granted by stakeholders to use the 
educational modules and all evidence-based research gathered to educate their staff on 
drug diversion in the future.   
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Limitations 
The project had several limitations which put into question the generalizability of 
the policy analysis findings.  The stakeholders present were members of research and 
quality improvement departments.  Therefore, the results of the policy analysis were not 
presented to other pertinent departments, such as pharmacy and anesthesia.  The 
procedures and policies used for the operating room are different, if you will, when 
compared to other areas of the hospital.  This difference is due to the types of drugs being 
used on a daily basis by anesthesia providers.  Effort was made to account for this 
limitation by emailing the chief anesthesiologist results of the drug diversion policy 
analysis and the suggested revision.  Also, personal bias of the DNP student and 
involvement as a student registered nurse anesthetist was a factor that could limit the 
internal validity of the project.  Acknowledging this personal bias ahead of time, the 
student was able to not only focus on anesthesia providers and drug diversion but to 
allow all types of healthcare providers be addressed.   
Conclusion  
Countless patients are put at risk of receiving substandard care by impaired 
healthcare personnel.  This poses very real implications for patient safety and should not 
go unnoticed.  Limiting the misuse and drug diversion of prescription drugs requires a 
coordinated approach between regulatory bodies, hospital administrations, pharmacy and 
individual health care providers.  The purpose of this DNP project was to perform a 
policy analysis on the drug diversion reporting and response policy at the institution of 
interest.  The policy analysis revealed a gap in the institution's language specifically to 
students utilizing the facility of interest for a clinical site.  The subtle discrepancies found 
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between the institution’s drug diversion policy and the best practice guidelines for such a 
policy were disseminated to the key stakeholders.  There was a unanimous decision by 
the participants that felt their institution's policy exhibited the need for revision and that 
this revision would be beneficial for the institution, therefore ensuring the safety of their 
patients.   
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APPENDIX A – Literature Matrix 
 
AUTHOR/YEAR/TITLE DESIGN SAMPLE/DATA FINDINGS RECOMMENDATIONS 
Bell, McDonough, Ellison, 
& Fitzhugh, (1999). 
Controlled drug misuse by 
certified registered nurse 
anesthetists 
A correlational 
study using self-
administered 
surveys to collect 
data 
2,500 subjects were 
randomly selected 
from actively 
practicing members 
of AANA. Of these, 
1,709 completed the 
survey with a 
response rate of 
68.4% 
9.8% prevalence 
of controlled drug 
misuse among 
CRNAS 
Male CRNA 6-10 
years of 
experience have 
increased risk for 
drug misuse 
 
Addiction education should be 
mandatory in anesthesia 
schools; most CRNAs feel 
their colleagues who 
successfully complete rehab 
should be permitted to re-enter 
the profession; however, after 
a relapse, most believe re-
entry should be denied 
Berge, Dillon, Sikkink, 
Taylor & Lanier. (2012) 
Diversion of drugs within 
healthcare facilities, a 
multiple victim crime: 
Patterns of diversion, 
scope, consequences, 
detection, and prevention 
Institution-wide 
Mayo Clinic 
Quality 
Improvement 
Effort 
Entire Mayo 
Healthcare system. 
Began in the 
anesthesia 
department in the 
OR and expanded 
throughout other 
departments with 
high use of 
controlled 
substances. 
Approximately 
75% of suspected 
drug diversion has 
been resolved 
through 
confession of the 
drug diverter 
 
Bozimowski, Groh, Rouen 
& Dosch, (2012). The 
prevalence and patterns of 
substance abuse among  
nurse anesthesia students 
Cross-sectional, 
retrospective 
study using 
electronic survey 
Program directors of 
111 accredited nurse 
anesthesia programs 
in the United States 
received the 
electronic survey. 
Of these, 23 PDs 
(21.7 % response 
rate) have complete 
data on prevalence 
and demographics 
and additional 24 
PDs (42.3% 
response rate) 
completed questions 
related to screening 
procedure and 
prevention strategies 
Prevalence of 
substance abuse 
was lower among 
SRNAs (0.65%) 
than CRNAs 
(9.8%), but the 
comparison is 
based on historical 
data. Opiate is the 
top drug of choice 
for SRNAs. 
Voluntary 
enrollment to 
treatment 
and dismissal 
from the program 
were the top 
reported outcomes 
of substance 
abuse. Drug 
testing for cause 
during the 
program was the 
top reported 
screening 
procedure 
Wellness 
activities, 
educational 
offerings and 
faculty support 
were among other 
themes. 
 
Future studies need to identify 
the effectiveness of wellness 
and prevention strategies, so 
anesthesia programs could be 
more proactive in promoting 
wellness, effective screening 
in their students as they 
transition from student to 
practitioner. 
 
 
Authors suggest further 
research is necessary to 
confirm.  
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AUTHOR/YEAR/TITLE DESIGN SAMPLE/DATA FINDINGS RECOMMENDATIONS 
Luck & Hendrick, (2004) 
The alarming trend of 
substance abuse in 
anesthesia providers 
Descriptive 
literature review 
NA Estimates of 
Addiction among 
anesthesia providers 
are as high as 15%. 
Midazolam and 
Nitrous Oxide are 
currently the drugs 
of choice for 
addicted anesthesia 
providers. 
 
 
Tetzlaff, (2011). Drug 
diversion, chemical 
dependence, and 
anesthesiology. 
Descriptive 
literature review 
 Estimates of 
Addiction among 
anesthesia 
dependency and the 
multiple factors that 
may lead to this.  
 
 
Tetzlaff, Collins, Brown, 
Leak, Pollock & Popa. 
(2010). A strategy to 
prevent substance abuse in 
an academic 
anesthesiology department. 
Quality 
Improvement 
The Cleveland 
Clinic's 
Anesthesiology 
Institute 
approached the 
process from the 
perspective of 
active prevention, 
including specific 
mandatory 
education 
programs for all 
department 
personnel on a 
recurring basis, 
strengthened 
procedures for the 
detection and 
prevention of 
diversion of 
controlled 
substances, 
enhanced skill 
building for 
detection of 
impairment, and 
implemented a 
multi-faceted drug 
testing program, 
including random 
and "for cause" 
urine screens, for 
prevention and 
early detection of 
abused anesthetic 
drugs and other 
substances of 
abuse.  
 
 
 After 18 months of 
preparation, a Substance 
Abuse Prevention Protocol 
was created, which has been 
fully implemented as of 
September 1, 2007. 
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AUTHOR/YEAR/TITLE DESIGN SAMPLE/DATA FINDINGS RECOMMENDATIONS 
Warner, Schaefer, Patel, 
Drobeniuc, Xia, Lin & 
Thompson.  (2015). The 
outbreak of hepatitis C 
virus infection associated 
with narcotics diversion by 
a hepatitis C virus-infected 
surgical technician 
Observational, 
epidemiological 
case finding and 
report 
Facility A: Total 
Patients N=4748 
Patients tested 
N=4066  
Facility B: Total 
Patients N=1222 
Patients tested 
N=1183 HCV 
infected surgical 
technician who 
was suspected of 
narcotic drug 
diversion and 
tampering of 
injectable 
narcotic, exposing 
patients to his 
HCV infected 
blood. 
18 confirmed cases 
of HCV from the 
surgical tech that 
diverted fentanyl 
from the anesthesia 
carts in the 
OR. Limitations 
include test results 
were not received 
from 674 patients. 
 
Wright, McGuiness, 
Moneyham, Schumacher, 
Zwerling & Stullengarger, 
(2012). 
“Opioid abuse among 
nurse anesthetists and 
anesthesiologists.” 
Qualitative 
Inquiry 
NA This article reviews 
the literature 
regarding opioid 
abuse and 
dependency among 
nurse anesthetist 
and 
anesthesiologists.   
More studies need to be 
conducted on the presence of 
these predisposing risk factors 
and how it influences the 
development of actual 
substance abuse during their 
careers.  Results could 
provide the foundation for a 
standardized approach 
amongst anesthesia programs.  
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APPENDIX B - Key Fact Sheet 
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APPENDIX C – Policy Analysis 
Current Best 
Practice Guidelines 
The Hospitals Drug 
Diversion/Reporting 
Policy 
The 
University’s 
Impaired 
Student 
Policy 
Recommended 
updates/edits to the 
hospital’s existing 
protocol 
Maintain clear and 
concise steps for 
employees/supervisors 
to follow when 
reporting drug 
diversion in student 
Does not have 
language regarding 
supervisors’ steps to 
take in contacting the 
university if a student 
is suspected 
States 
“program 
director, 
department 
chair and 
associate dean 
will be 
notified” 
“the faculty 
member will 
confront the 
student with 
the behavior 
observed” 
“if an FGH fellow, 
resident, medical 
student (include any 
type of learner) is 
suspected of 
diverting drugs 
within the scope of 
their training by the 
Committee D at 
FGH/Designated 
Nurses, the point of 
the program of 
contact 
administrator should 
be notified. 
(language needs to 
be specific for each 
program utilizing 
FGH as a clinical 
site). 
If a USM SRNA is 
suspected of 
diverting drugs 
within the scope of 
their training, the 
USM NAP Program 
administrator will 
be notified 
immediately and 
any further contact 
deemed necessary 
will be done so by 
the program 
administrator.  
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Financial 
Responsibility of 
hospital  
No guidelines exist “the faculty 
member will 
request an 
alcohol or 
drug screen. 
The CON will 
assume the 
cost of the 
alcohol or 
drug screen” 
Add language to 
current policy 
stating the program 
administrator will 
be notified of a 
student suspected 
and/or confirmed 
behavior and 
financial 
obligations, such as 
drug testing fees, 
will be covered by 
the CONHP 
(College of nursing 
and health 
professionals), as 
stated in USM’s 
impaired nursing 
student policy.   
What to do with the 
student once a drug 
test is done, etc 
No guidelines exist “the student 
will be 
immediately 
suspended 
from the 
nursing 
program (not 
from the 
University)  
Add Language 
addressing the 
hospitals 
responsibility once a 
student has tested 
positive or denied 
drug test. Suggested 
language is as 
follows: If an FGH 
resident or medical 
student admits 
substance abuse and 
tests positive, policy 
guidelines as stated 
in the specific 
program's policy 
will be followed. An 
employee will 
remain with the 
student until a 
program 
administrator or 
designated person 
arrives (will need to 
include a specific 
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person of contact for 
other programs)   
 
If a USM nurse 
anesthesia student 
admits to substance, 
test positive or 
denies drug screen 
test, the USM NAP 
administrator will 
be notified 
immediately. An 
employee will 
remain with the 
SRNA until NAP 
administrator or 
designated person 
arrives. The USM 
NAP program 
administrator or 
representative will 
then allow the 
student to be 
released to a 
responsible adult.  
Recommendations 
also include 
language stating that 
suspected and/or 
confirmed impaired 
provider should not 
be allowed to 
operate a vehicle.  
Reporting to law 
enforcement, licensing 
boards, and other 
government agencies 
“drug diversion by an 
employee will be 
reported to all 
appropriate 
government, 
licensing, regulatory 
and law enforcement 
agencies” 
Lacks clear 
guidelines 
Suggested change in 
language: “Any 
follow-up and/or 
further reporting, 
such as notifying 
Board of Nursing or 
police department 
will be decided by 
the FGH Committee 
D/Designated nurses 
and The USM NAP 
Administrator”. 
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APPENDIX D- SWOT Analysis 
 
Strengths  Weaknesses 
• No cost to the institution 
• Comprehensive policy analysis 
• Administration and anesthesia 
department support of the 
project 
 
• Compliance from health care 
employees to follow policy 
guidelines 
• Bias criticism from different 
departments and their views on 
policy 
• Associated guilt/fear with 
reporting an employee 
Opportunities Threats 
• To provide a safe and 
confidential process for 
reporting drug diversion 
• Fewer adverse event associated 
with an impaired employee 
 
• Resistance to change by all 
employees 
• Resistance to change and/or 
disinterest by administration 
and university  
• Employees not reporting due to 
fear of a breach in 
confidentiality  
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